Design, synthesis and SAR study of bridged tricyclic pyrimidinone carboxamides as HIV-1 integrase inhibitors

被引：8

作者：

Patel, Manoj ^{[1
,5
]}

Naidu, B. Narasimhulu ^{[1
,5
]}

Dicker, Ira ^{[2
,5
]}

Higley, Helen ^{[2
]}

Lin, Zeyu ^{[2
]}

Terry, Brian ^{[2
]}

Protack, Tricia ^{[2
]}

Krystal, Mark ^{[2
,5
]}

Jenkins, Susan ^{[1
,5
]}

Parker, Dawn ^{[1
,5
]}

Panja, Chiradeep ^{[3
]}

Rampulla, Richard ^{[4
]}

Mathur, Arvind ^{[4
]}

Meanwell, Nicholas A. ^{[1
]}

Walker, Michael A. ^{[1
,6
]}

机构：

[1] Dept Discovery Chem & Mol Technol, 5 Res Pkwy, Wallingford, CT 06492 USA

[2] Bristol Myers Squibb Res & Dev, Virol, 5 Res Pkwy, Wallingford, CT 06492 USA

[3] Biocon Bristol Myers Squibb Res Ctr, Plot 2&3,Bommasandra Ind Estate Phase 4, Bengaluru 560099, Karnataka, India

[4] Bristol Myers Squibb Res & Dev, Dept Discovery Chem Synth, POB 4000, Princeton, NJ 08543 USA

[5] ViiV Healthcare, 36 East Ind Pkwy, Branford, CT 06405 USA

[6] Assembly Biosci Inc, 331 Oyster Point Blvd, San Francisco, CA 94080 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY | 2020年 / 28卷 / 13期

关键词：

RALTEGRAVIR RESISTANCE; DOLUTEGRAVIR; ELVITEGRAVIR; MUTATIONS; EVOLUTION;

D O I：

10.1016/j.bmc.2020.115541

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

The design, synthesis and structure-activity relationships associated with a series of bridged tricyclic pyrimidinone carboxamides as potent inhibitors of HIV-1 integrase strand transfer are described. Structural modifications to these molecules were made in order to examine the effect on potency towards wild-type and clinically-relevant resistant viruses. The [3.2.2]-bridged tricyclic system was identified as an advantageous chemotype, with representatives exhibiting excellent antiviral activity against both wild-type viruses and the G140S/Q148H resistant virus that arises in response to therapy with raltegravir and elvitegravir. © 2020 Elsevier Ltd

引用

页数：6

共 50 条

[31] Synthesis and biological evaluation of HIV-1 integrase inhibitors.
Gervay-Hague, J
Meadows, DC
Hadd, MJ
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 225 : U179 - U179
[32] The future of integrase inhibitors of HIV-1
Malet, Isabelle
Calvez, Vincent
Marcelin, Anne-Genevieve
CURRENT OPINION IN VIROLOGY, 2012, 2 (05) : 580 - 587
[33] The hunt for HIV-1 integrase inhibitors
Lataillade, Max
Kozal, Michael J.
AIDS PATIENT CARE AND STDS, 2006, 20 (07) : 489 - 501
[34] Arylamide inhibitors of HIV-1 integrase
Zhao, H
Neamati, N
Mazumder, A
Sunder, S
Pommier, Y
Burke, TR
JOURNAL OF MEDICINAL CHEMISTRY, 1997, 40 (08) : 1186 - 1194
[35] Tricyclic HIV integrase inhibitors V. SAR studies on the benzyl moiety
Jin, Haolun
Metobo, Sammy
Jabri, Salman
Mish, Michael
Lansdown, Rachael
Chen, Xiaowu
Tsiang, Manuel
Wright, Matthew
Kim, Choung U.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (08) : 2263 - 2265
[36] Synthesis of novel thiazolothiazepine based HIV-1 integrase inhibitors
Aiello, F
Brizzi, A
Garofalo, A
Grande, F
Ragno, G
Dayam, R
Neamati, N
BIOORGANIC & MEDICINAL CHEMISTRY, 2004, 12 (16) : 4459 - 4466
[37] Thiazolothiazepine inhibitors of HIV-1 integrase
Neamati, N
Turpin, JA
Winslow, HE
Christensen, JL
Williamson, K
Orr, A
Rice, WG
Pommier, Y
Garofalo, A
Brizzi, A
Campiani, G
Fiorini, I
Nacci, V
JOURNAL OF MEDICINAL CHEMISTRY, 1999, 42 (17) : 3334 - 3341
[38] Authentic HIV-1 integrase inhibitors
Liao, Chenzhong
Marchand, Christophe
Burke, Terrence R., Jr.
Pommier, Yves
Nicklaus, Marc C.
FUTURE MEDICINAL CHEMISTRY, 2010, 2 (07) : 1107 - 1122
[39] Naphthoxazepine inhibitors of HIV-1 integrase: Synthesis and biological evaluation
Garofalo, Antonio
Grande, Fedora
Brizzi, Antonella
Aiello, Francesca
Dayam, Raveendra
Neamati, Nouri
CHEMMEDCHEM, 2008, 3 (06) : 986 - 990
[40] The synthesis of tetrahydropyridopyrimidones as a new scaffold for HIV-1 integrase inhibitors
Kinzel, Olaf D.
Monteagudo, Edith
Muraglia, Ester
Orvieto, Federica
Pescatore, Giovanna
del Rosario, Maria
Ferreira, Rico
Rowley, Michael
Summa, Vincenzo
TETRAHEDRON LETTERS, 2007, 48 (37) : 6552 - 6555

← 1 2 3 4 5 →